{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T04:44:07Z","timestamp":1792557847038,"version":"4.5.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:00:00Z","timestamp":1679875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100001512","name":"National Brain Tumor Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001512","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA021765"],"award-info":[{"award-number":["P30 CA021765"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012524","name":"American Lebanese Syrian Associated Charities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012524","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pediatric high-grade glioma (pHGG) is largely incurable and accounts for most brain tumor-related deaths in children. Radiation is a standard therapy, yet the benefit from this treatment modality is transient, and most children succumb to disease within 2 years. Recent large-scale genomic studies suggest that pHGG has alterations in DNA damage response (DDR) pathways that induce resistance to DNA damaging agents. The aim of this study was to evaluate the therapeutic potential and molecular consequences of combining radiation with selective DDR inhibition in pHGG.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted an unbiased screen in pHGG cells that combined radiation with clinical candidates targeting the DDR and identified the ATM inhibitor AZD1390. Subsequently, we profiled AZD1390 + radiation in an extensive panel of early passage pHGG cell lines, mechanistically characterized response to the combination in vitro in sensitive and resistant cells and evaluated the combination in vivo using TP53 wild-type and TP53 mutant orthotopic xenografts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>AZD1390 significantly potentiated radiation across molecular subgroups of pHGG by increasing mutagenic nonhomologous end joining and augmenting genomic instability. In contrast to previous reports, ATM inhibition significantly improved the efficacy of radiation in both TP53 wild-type and TP53 mutant isogenic cell lines and distinct orthotopic xenograft models. Furthermore, we identified a novel mechanism of resistance to AZD1390 + radiation that was marked by an attenuated ATM pathway response which dampened sensitivity to ATM inhibition and induced synthetic lethality with ATR inhibition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our study supports the clinical evaluation of AZD1390 in combination with radiation in pediatric patients with HGG.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/neuonc\/noad064","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T06:50:27Z","timestamp":1679899827000},"page":"1828-1841","source":"Crossref","is-referenced-by-count":26,"title":["ATM inhibition enhances the efficacy of radiation across distinct molecular subgroups of pediatric high-grade glioma"],"prefix":"10.1093","volume":"25","author":[{"given":"Jia","family":"Xie","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, St. Jude Children\u2019s Research Hospital , Memphis, Tennessee 38105 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teneema","family":"Kuriakose","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, St. Jude Children\u2019s Research Hospital , Memphis, Tennessee 38105 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Bianski","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, St. Jude Children\u2019s Research Hospital , Memphis, Tennessee 38105 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel","family":"Twarog","sequence":"additional","affiliation":[{"name":"Department of Chemical Biology and Therapeutics, St. Jude Children\u2019s Research Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Savage","sequence":"additional","affiliation":[{"name":"Department of Chemical Biology and Therapeutics, St. Jude Children\u2019s Research Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Xu","sequence":"additional","affiliation":[{"name":"Center for Applied Bioinformatics, St. Jude Children\u2019s Research Hospital , Memphis , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Developmental Neurobiology, St. Jude Children\u2019s Research Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"He","sequence":"additional","affiliation":[{"name":"Department of Developmental Neurobiology, St. Jude Children\u2019s Research Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baranda","family":"Hansen","sequence":"additional","affiliation":[{"name":"Center for Advanced Genome Engineering, St. Jude Children\u2019s Research Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[{"name":"Center for Proteomics and Metabolomics, St. Jude Children\u2019s Research Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"High","sequence":"additional","affiliation":[{"name":"Center for Proteomics and Metabolomics, St. Jude Children\u2019s Research Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Li","sequence":"additional","affiliation":[{"name":"Center for Proteomics and Metabolomics, St. Jude Children\u2019s Research Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerold E","family":"Rehg","sequence":"additional","affiliation":[{"name":"Department of Pathology, St. Jude Children\u2019s Research Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather S","family":"Tillman","sequence":"additional","affiliation":[{"name":"Department of Pathology, St. Jude Children\u2019s Research Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Burgess B","family":"Freeman","sequence":"additional","affiliation":[{"name":"Preclinical Pharmacokinetic Shared Resource, St. Jude Children\u2019s Research Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoran","family":"Rankovic","sequence":"additional","affiliation":[{"name":"Department of Chemical Biology and Therapeutics, St. Jude Children\u2019s Research Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arzu","family":"Onar-Thomas","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, St. Jude Children\u2019s Research Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Fan","sequence":"additional","affiliation":[{"name":"Center for Applied Bioinformatics, St. Jude Children\u2019s Research Hospital , Memphis , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1678-5864","authenticated-orcid":false,"given":"Gang","family":"Wu","sequence":"additional","affiliation":[{"name":"Center for Applied Bioinformatics, St. Jude Children\u2019s Research Hospital , Memphis , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junmin","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Developmental Neurobiology, St. Jude Children\u2019s Research Hospital"},{"name":"Center for Proteomics and Metabolomics, St. Jude Children\u2019s Research Hospital"},{"name":"Department of Structural Biology, St. Jude Children\u2019s Research Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shondra","family":"Miller","sequence":"additional","affiliation":[{"name":"Center for Advanced Genome Engineering, St. Jude Children\u2019s Research Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne J","family":"Baker","sequence":"additional","affiliation":[{"name":"Department of Developmental Neurobiology, St. Jude Children\u2019s Research Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anang A","family":"Shelat","sequence":"additional","affiliation":[{"name":"Department of Chemical Biology and Therapeutics, St. Jude Children\u2019s Research Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5552-2664","authenticated-orcid":false,"given":"Christopher L","family":"Tinkle","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, St. Jude Children\u2019s Research Hospital , Memphis, Tennessee 38105 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,3,27]]},"reference":[{"key":"2023100321325849100_CIT0001","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.pharmthera.2017.08.006","article-title":"Molecular pathogenesis and therapeutic implications in pediatric high-grade gliomas","volume":"182","author":"Juratli","year":"2018","journal-title":"Pharmacol Ther."},{"issue":"5","key":"2023100321325849100_CIT0002","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0360-3016(98)00501-X","article-title":"There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy","volume":"43","author":"Mandell","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"10","key":"2023100321325849100_CIT0003","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/neuonc\/nor092","article-title":"Treatment of high-grade glioma in children and adolescents","volume":"13","author":"MacDonald","year":"2011","journal-title":"Neuro Oncol"},{"issue":"4","key":"2023100321325849100_CIT0004","first-page":"145","article-title":"Management of high-grade gliomas in the pediatric patient: Past, present, and future","volume":"1","author":"Vanan","year":"2014","journal-title":"Neurooncol Pract"},{"issue":"4","key":"2023100321325849100_CIT0005","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ccell.2017.08.017","article-title":"Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma","volume":"32","author":"Mackay","year":"2017","journal-title":"Cancer Cell"},{"key":"2023100321325849100_CIT0006","doi-asserted-by":"crossref","first-page":"662209","DOI":"10.3389\/fonc.2021.662209","article-title":"Radiosensitization in pediatric high-grade glioma: targets, resistance and developments","volume":"11","author":"Metselaar","year":"2021","journal-title":"Front Oncol."},{"issue":"8","key":"2023100321325849100_CIT0007","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11912-021-01077-z","article-title":"DNA repair mechanisms and therapeutic targets in glioma","volume":"23","author":"Elmore","year":"2021","journal-title":"Curr Oncol Rep."},{"issue":"10","key":"2023100321325849100_CIT0008","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med."},{"issue":"3","key":"2023100321325849100_CIT0009","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/neuonc\/noq191","article-title":"Temozolomide in the treatment of high-grade gliomas in children: a report from the children\u2019s oncology group","volume":"13","author":"Cohen","year":"2011","journal-title":"Neuro Oncol"},{"issue":"4","key":"2023100321325849100_CIT0010","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/neuonc\/noq205","article-title":"Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children\u2019s Oncology Group","volume":"13","author":"Cohen","year":"2011","journal-title":"Neuro Oncol"},{"issue":"1","key":"2023100321325849100_CIT0011","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1038\/s41467-021-24168-8","article-title":"Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade glioma","volume":"12","author":"He","year":"2021","journal-title":"Nat Commun."},{"issue":"1","key":"2023100321325849100_CIT0012","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1038\/s41467-019-11661-4","article-title":"Deep multiomics profiling of brain tumors identifies signaling networks downstream of cancer driver genes","volume":"10","author":"Wang","year":"2019","journal-title":"Nat Commun."},{"issue":"3","key":"2023100321325849100_CIT0013","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ijrobp.2018.10.015","article-title":"Preclinical modeling of image-guided craniospinal irradiation for very-high-risk medulloblastoma","volume":"103","author":"Smith","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"2023100321325849100_CIT0014","doi-asserted-by":"crossref","first-page":"25523","DOI":"10.1038\/srep25523","article-title":"BRAID: a unifying paradigm for the analysis of combined drug action","volume":"6","author":"Twarog","year":"2016","journal-title":"Sci Rep."},{"issue":"2","key":"2023100321325849100_CIT0015","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4103\/0971-5851.158838","article-title":"Outcomes of pediatric glioblastoma treated with adjuvant chemoradiation with temozolomide and correlation with prognostic factors","volume":"36","author":"Mallick","year":"2015","journal-title":"Indian J Med Paediatr Oncol"},{"issue":"1","key":"2023100321325849100_CIT0016","first-page":"vdac073","article-title":"Wee1 kinase inhibitor adavosertib with radiation in newly diagnosed diffuse intrinsic pontine glioma: a children\u2019s oncology group phase I consortium study","volume":"4","author":"Mueller","year":"2022","journal-title":"Neurooncol Adv"},{"issue":"14","key":"2023100321325849100_CIT0017","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1158\/0008-5472.CAN-17-3691","article-title":"Dual HDAC and PI3K inhibition abrogates NFkappaB- and FOXM1-Mediated DNA damage response to radiosensitize pediatric high-grade gliomas","volume":"78","author":"Pal","year":"2018","journal-title":"Cancer Res."},{"issue":"22","key":"2023100321325849100_CIT0018","doi-asserted-by":"crossref","first-page":"6788","DOI":"10.1158\/1078-0432.CCR-19-0126","article-title":"TP53 pathway alterations drive radioresistance in Diffuse Intrinsic Pontine Gliomas (DIPG)","volume":"25","author":"Werbrouck","year":"2019","journal-title":"Clin Cancer Res."},{"issue":"6","key":"2023100321325849100_CIT0019","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00401-015-1478-0","article-title":"Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes","volume":"130","author":"Castel","year":"2015","journal-title":"Acta Neuropathol."},{"issue":"11","key":"2023100321325849100_CIT0020","doi-asserted-by":"crossref","first-page":"e115e115","DOI":"10.1093\/nar\/gkt255","article-title":"Development of an assay to measure mutagenic non-homologous end-joining repair activity in mammalian cells","volume":"41","author":"Bindra","year":"2013","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"2023100321325849100_CIT0021","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10565-007-9043-9","article-title":"Comet assay measurements: a perspective","volume":"25","author":"Kumaravel","year":"2009","journal-title":"Cell Biol Toxicol."},{"issue":"11","key":"2023100321325849100_CIT0022","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/s12276-020-00529-z","article-title":"Small but mighty: the causes and consequences of micronucleus rupture","volume":"52","author":"Kwon","year":"2020","journal-title":"Exp Mol Med."},{"issue":"6","key":"2023100321325849100_CIT0023","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/psp4.12627","article-title":"Model-based evaluation of image-guided fractionated whole-brain radiation therapy in pediatric diffuse intrinsic pontine glioma xenografts","volume":"10","author":"Husband","year":"2021","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"4","key":"2023100321325849100_CIT0024","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","article-title":"Causal analysis approaches in Ingenuity Pathway Analysis","volume":"30","author":"Kr\u00e4mer","year":"2014","journal-title":"Bioinformatics."},{"issue":"268","key":"2023100321325849100_CIT0025","doi-asserted-by":"crossref","first-page":"rs6","DOI":"10.1126\/scisignal.2003573","article-title":"Kinase-substrate enrichment analysis provides insights into the heterogeneity of signaling pathway activation in leukemia cells","volume":"6","author":"Casado","year":"2013","journal-title":"Sci Signal"},{"issue":"43","key":"2023100321325849100_CIT0026","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci USA."},{"issue":"2","key":"2023100321325849100_CIT0027","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1667\/RADE-20-00009","article-title":"The roles of autophagy and senescence in the tumor cell response to radiation","volume":"194","author":"Patel","year":"2020","journal-title":"Radiat Res."},{"issue":"3","key":"2023100321325849100_CIT0028","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/ijc.24402","article-title":"The induction of autophagy by gamma-radiation contributes to the radioresistance of glioma stem cells","volume":"125","author":"Lomonaco","year":"2009","journal-title":"Int J Cancer."},{"issue":"21","key":"2023100321325849100_CIT0029","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1093\/emboj\/19.21.5720","article-title":"LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing","volume":"19","author":"Kabeya","year":"2000","journal-title":"EMBO J."},{"issue":"27","key":"2023100321325849100_CIT0030","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1200\/JCO.19.02404","article-title":"Phase I trial of first-in-class ATR Inhibitor M6620 (VX-970) as monotherapy or in combination with carboplatin in patients with advanced solid tumors","volume":"38","author":"Yap","year":"2020","journal-title":"J Clin Oncol."},{"issue":"1","key":"2023100321325849100_CIT0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI142158","article-title":"Tumor genotype dictates radiosensitization after Atm deletion in primary brainstem glioma models","volume":"131","author":"Deland","year":"2021","journal-title":"J Clin Invest."},{"issue":"20","key":"2023100321325849100_CIT0032","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.4161\/cc.9.20.13471","article-title":"Inhibition of ATM kinase activity does not phenocopy ATM protein disruption: implications for the clinical utility of ATM kinase inhibitors","volume":"9","author":"Choi","year":"2010","journal-title":"Cell Cycle"},{"issue":"12","key":"2023100321325849100_CIT0033","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1158\/1078-0432.CCR-12-3408","article-title":"ATM kinase inhibition preferentially sensitizes p53-mutant glioma to ionizing radiation","volume":"19","author":"Biddlestone-Thorpe","year":"2013","journal-title":"Clin Cancer Res."},{"issue":"16","key":"2023100321325849100_CIT0034","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1101\/gad.1815309","article-title":"The combined status of ATM and p53 link tumor development with therapeutic response","volume":"23","author":"Jiang","year":"2009","journal-title":"Genes Dev."},{"issue":"6","key":"2023100321325849100_CIT0035","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/ijc.29121","article-title":"Pharmacokinetics, pharmacodynamics and efficacy on pediatric tumors of the glioma radiosensitizer KU60019","volume":"136","author":"Vecchio","year":"2015","journal-title":"Int J Cancer."},{"issue":"6","key":"2023100321325849100_CIT0036","doi-asserted-by":"crossref","first-page":"eaat1719","DOI":"10.1126\/sciadv.aat1719","article-title":"The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models","volume":"4","author":"Durant","year":"2018","journal-title":"Sci Adv."},{"issue":"7","key":"2023100321325849100_CIT0037","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/ng.2995","article-title":"Exome sequencing identifies somatic gain-of-function PPM1D mutations in brainstem gliomas","volume":"46","author":"Zhang","year":"2014","journal-title":"Nat Genet."}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/advance-article-pdf\/doi\/10.1093\/neuonc\/noad064\/50097440\/noad064.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/25\/10\/1828\/51840853\/noad064.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/25\/10\/1828\/51840853\/noad064.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T17:34:12Z","timestamp":1696354452000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/25\/10\/1828\/7086676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,27]]},"references-count":37,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,3,27]]},"published-print":{"date-parts":[[2023,10,3]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noad064","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,10,1]]},"published":{"date-parts":[[2023,3,27]]}}}